CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands |
Total |
Sonder Legacy Warrants |
Delayed Draw Warrants |
Previously Reported |
Additional Paid-in Capital |
Additional Paid-in Capital
Sonder Legacy Warrants
|
Additional Paid-in Capital
Delayed Draw Warrants
|
Additional Paid-in Capital
Previously Reported
|
Accumulated Translation Adjustment |
Accumulated Translation Adjustment
Previously Reported
|
Accumulated Deficit |
Accumulated Deficit
Previously Reported
|
Redeemable convertible preferred stock |
Redeemable convertible preferred stock
Previously Reported
|
Redeemable convertible preferred stock
Revision of Prior Period, Adjustment
|
Redeemable convertible preferred stock
Common Stock
|
Exchangeable preferred stock |
Exchangeable preferred stock
Previously Reported
|
Exchangeable preferred stock
Revision of Prior Period, Adjustment
|
Common Stock
Common Stock
|
Common Stock
Common Stock
Sonder Legacy Warrants
|
Common Stock
Common Stock
Previously Reported
|
Common Stock
Common Stock
Revision of Prior Period, Adjustment
|
Exchangeable AA Stock
Common Stock
|
Exchangeable AA Stock
Common Stock
Previously Reported
|
Exchangeable AA Stock
Common Stock
Revision of Prior Period, Adjustment
|
Post-Combination Exchangeable Common Shares |
Post-Combination Exchangeable Common Shares
Common Stock
|
Post-Combination Exchangeable Common Shares
Common Stock
Previously Reported
|
Post-Combination Exchangeable Common Shares
Common Stock
Revision of Prior Period, Adjustment
|
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
83,348,449
|
56,753,734
|
26,594,715
|
|
17,856,961
|
12,159,185
|
5,697,776
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, beginning balance at Dec. 31, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
$ 314,967
|
$ 314,967
|
|
|
$ 45,203
|
$ 45,203
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Mezzanine Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series D Redeemable convertible Preferred Stock extension round (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
69,960
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series D Redeemable convertible Preferred Stock extension round |
|
|
|
|
|
|
|
|
|
|
|
|
$ 594
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Series E Convertible Preferred Stock/Exchangeable Series E Preferred Stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
27,702,626
|
|
|
|
656,438
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Series E Convertible Preferred Stock/Exchangeable Series E Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
$ 202,169
|
|
|
|
$ 4,530
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, ending balance (in shares) at Dec. 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
111,121,035
|
|
|
|
18,513,399
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, ending balance at Dec. 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
$ 517,730
|
|
|
|
$ 49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning balance (in shares) at Dec. 31, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,379,192
|
|
5,705,570
|
2,673,622
|
14,454,797
|
9,842,579
|
4,612,218
|
|
0
|
0
|
0
|
Beginning balance at Dec. 31, 2019 |
$ (258,670)
|
|
|
$ (258,670)
|
$ 5,032
|
|
|
$ 5,032
|
$ 6,406
|
$ 6,406
|
$ (270,109)
|
$ (270,109)
|
|
|
|
|
|
|
|
$ 1
|
|
$ 1
|
|
$ 0
|
$ 0
|
|
|
$ 0
|
$ 0
|
|
Increase (Decrease) in Stockholders' Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange of Series AA Special Voting shares for common stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
595,107
|
|
|
|
(595,107)
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,555,197
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options |
1,643
|
|
|
|
1,643
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
7,223
|
|
|
|
7,223
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(250,316)
|
|
|
|
|
|
|
|
|
|
(250,316)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cumulative translation adjustment |
(740)
|
|
|
|
|
|
|
|
(740)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Dec. 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,529,496
|
|
|
|
13,859,690
|
|
|
|
0
|
|
|
Ending balance at Dec. 31, 2020 |
(500,860)
|
|
|
|
13,898
|
|
|
|
5,666
|
|
(520,425)
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
$ 0
|
|
|
|
$ 0
|
|
|
Increase (Decrease) in Mezzanine Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Series E Convertible Preferred Stock/Exchangeable Series E Preferred Stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
136,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Series E Convertible Preferred Stock/Exchangeable Series E Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange of Exchangeable Preferred Stock to Convertible Preferred Stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
13,991
|
|
|
|
(13,991)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, ending balance (in shares) at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
111,271,424
|
75,767,082
|
|
|
18,499,408
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, ending balance at Dec. 31, 2021 |
$ 568,483
|
|
|
|
|
|
|
|
|
|
|
|
$ 518,750
|
|
|
|
$ 49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange of Series AA Special Voting shares for common stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,744
|
|
|
|
(23,744)
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options (in shares) |
2,225,859
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,116,610
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options |
$ 3,841
|
|
|
|
3,841
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock warrants (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
82,352
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock warrants |
120
|
|
|
|
120
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
25,247
|
|
|
|
25,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(294,387)
|
|
|
|
|
|
|
|
|
|
(294,387)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cumulative translation adjustment |
1,633
|
|
|
|
|
|
|
|
1,633
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,752,202
|
|
|
|
13,835,946
|
|
|
|
0
|
|
|
Ending balance at Dec. 31, 2021 |
(764,406)
|
|
|
|
43,106
|
|
|
|
7,299
|
|
(814,812)
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
$ 0
|
|
|
|
$ 0
|
|
|
Increase (Decrease) in Mezzanine Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of preferred stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
(111,271,424)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
$ (518,750)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock in connection with the business combination (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(18,499,408)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock in connection with the business combination |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (49,733)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, ending balance (in shares) at Dec. 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mezzanine equity, ending balance at Dec. 31, 2022 |
0
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
$ 0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Deficit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Sonder Legacy Warrants from liabilities to equity |
2,111
|
|
|
|
2,111
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CEO promissory note settlement (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,725,631)
|
|
|
|
|
|
|
|
|
|
|
Conversion of Sonder Legacy Warrants (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
155,239
|
|
|
|
|
|
|
|
|
|
Conversion of Sonder Legacy Warrants |
|
$ 1,243
|
|
|
|
$ 1,243
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of convertible note (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,017,105
|
|
|
|
|
|
|
|
|
|
|
Conversion of convertible note |
159,173
|
|
|
|
159,172
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
|
|
|
|
|
|
|
Conversion of preferred stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
111,271,424
|
|
|
|
|
|
|
|
|
|
|
Conversion of preferred stock |
$ 518,761
|
|
|
|
518,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 11
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options (in shares) |
931,362
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
931,362
|
|
|
|
|
|
|
|
|
|
|
Exercise of common stock options |
$ 1,620
|
|
|
|
1,620
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock in connection with Business Combination and PIPE offering (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,845,835
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock in connection with the business combination and PIPE offering |
267,362
|
|
|
|
267,355
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7
|
|
|
|
|
|
|
|
|
|
|
Assumption of SPAC Warrants upon consummation of business combination |
(25,985)
|
|
|
|
(25,985)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earn Out liability recognized upon consummation of business combination |
(98,117)
|
|
|
|
(98,117)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Delayed Draw Warrants |
|
|
$ 5,598
|
|
|
|
$ 5,598
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock in connection with the business combination (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13,835,946)
|
|
|
|
32,335,354
|
|
|
Conversion of exchangeable stock in connection with the business combination |
49,733
|
|
|
|
49,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,200,657
|
|
|
|
|
|
|
|
|
|
|
Vesting of restricted stock units |
58
|
|
|
|
58
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of exchangeable stock (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,946,138
|
|
|
|
0
|
|
|
|
(11,946,138)
|
|
|
Conversion of exchangeable stock |
1
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
22,957
|
|
|
|
22,957
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
(165,742)
|
|
|
|
|
|
|
|
|
|
(165,742)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cumulative translation adjustment |
5,686
|
|
|
|
|
|
|
|
5,686
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ending balance (in shares) at Dec. 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
198,394,331
|
|
|
|
0
|
|
|
20,389,216
|
20,389,216
|
|
|
Ending balance at Dec. 31, 2022 |
$ (19,947)
|
|
|
|
$ 947,601
|
|
|
|
$ 12,985
|
|
$ (980,554)
|
|
|
|
|
|
|
|
|
$ 21
|
|
|
|
$ 0
|
|
|
|
$ 0
|
|
|